Similar to results demonstrated with other 4-1BB agonist mAbs [1,7,13], MAB9371 induced CD8 T cell expansion, increased the proportion of CD8 T effector memory populations, and demonstrated tumor regression including long term anti-tumor immune memory. The gene discussed is CD8A; the disease is neoplasm.